Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

For information concerning this clinical site, please contact Nymox at 800-936-9669., New York

For information concerning this clinical site, please contact Nymox at 800-936-9669., Garden City

For information concerning this clinical site, please contact Nymox at 800-936-9669., Glen Burnie

For information concerning this clinical site, please contact Nymox at 800-936-9669., Towson

For information concerning this clinical site, please contact Nymox at 800-936-9669., Baltimore

For information concerning this clinical site, please contact Nymox at 800-936-9669., Annapolis

For information concerning this clinical site, please contact Nymox at 800-936-9669., Aventura

For information concerning this clinical site, please contact Nymox at 800-936-9669., Naples

For information concerning this clinical site, please contact Nymox at 800-936-9669., Columbus

For information concerning this clinical site, please contact Nymox at 800-936-9669., Jeffersonville

For information concerning this clinical site, please contact Nymox at 800-936-9669., Missoula

For information concerning this clinical site, please contact Nymox at 800-936-9669., Shreveport

For information concerning this clinical site, please contact Nymox at 800-936-9669., Dallas

For information concerning this clinical site, please contact Nymox at 800-936-9669., Meridian

For information concerning this clinical site, please contact Nymox at 800-936-9669., San Diego

For information concerning this clinical site, please contact Nymox at 800-936-9669., Laguna Beach

For information concerning this clinical site, please contact Nymox at 800-936-9669., Brick